HRP20180275T1 - Sustav zavoja - Google Patents

Sustav zavoja Download PDF

Info

Publication number
HRP20180275T1
HRP20180275T1 HRP20180275TT HRP20180275T HRP20180275T1 HR P20180275 T1 HRP20180275 T1 HR P20180275T1 HR P20180275T T HRP20180275T T HR P20180275TT HR P20180275 T HRP20180275 T HR P20180275T HR P20180275 T1 HRP20180275 T1 HR P20180275T1
Authority
HR
Croatia
Prior art keywords
nitrite
hydrogel
skin
ulceration
wound
Prior art date
Application number
HRP20180275TT
Other languages
English (en)
Croatian (hr)
Inventor
Christopher Barry Wood
Hugh Semple Munro
Nicholas David Boote
Joanne Ellen Stewart
Arthur Tudor Tucker
Original Assignee
Edixomed Limited
First Water Limited
Queen Mary University Of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edixomed Limited, First Water Limited, Queen Mary University Of London filed Critical Edixomed Limited
Publication of HRP20180275T1 publication Critical patent/HRP20180275T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymers & Plastics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HRP20180275TT 2013-05-20 2014-05-20 Sustav zavoja HRP20180275T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1309091.5A GB201309091D0 (en) 2013-05-20 2013-05-20 Dressing system
PCT/GB2014/051543 WO2014188174A1 (en) 2013-05-20 2014-05-20 Dressing system
EP14726729.8A EP2908872B1 (en) 2013-05-20 2014-05-20 Dressing system

Publications (1)

Publication Number Publication Date
HRP20180275T1 true HRP20180275T1 (hr) 2018-04-20

Family

ID=48747064

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20180275TT HRP20180275T1 (hr) 2013-05-20 2014-05-20 Sustav zavoja

Country Status (17)

Country Link
US (1) US9662414B2 (cg-RX-API-DMAC7.html)
EP (1) EP2908872B1 (cg-RX-API-DMAC7.html)
JP (1) JP6559655B2 (cg-RX-API-DMAC7.html)
CN (1) CN105579074B (cg-RX-API-DMAC7.html)
AU (1) AU2014270115B2 (cg-RX-API-DMAC7.html)
DK (1) DK2908872T3 (cg-RX-API-DMAC7.html)
ES (1) ES2661643T3 (cg-RX-API-DMAC7.html)
GB (1) GB201309091D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20180275T1 (cg-RX-API-DMAC7.html)
HU (1) HUE038361T2 (cg-RX-API-DMAC7.html)
LT (1) LT2908872T (cg-RX-API-DMAC7.html)
NO (1) NO2908872T3 (cg-RX-API-DMAC7.html)
PL (1) PL2908872T3 (cg-RX-API-DMAC7.html)
PT (1) PT2908872T (cg-RX-API-DMAC7.html)
RS (1) RS56954B1 (cg-RX-API-DMAC7.html)
SA (1) SA515370167B1 (cg-RX-API-DMAC7.html)
WO (1) WO2014188174A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201309092D0 (en) * 2013-05-20 2013-07-03 Edixomed Ltd Transdermal delivery system
GB201420761D0 (en) 2014-11-21 2015-01-07 Edixomed Ltd And First Water Ltd Dressing system
GB201520990D0 (en) 2015-11-27 2016-01-13 Edixomed Ltd Dressing system
US11506658B2 (en) 2019-04-24 2022-11-22 Progenitec, Inc. System for analysis of body fluids and wound-associated biomolecules
BR112021023832A8 (pt) 2019-06-04 2023-02-28 Thirty Holdings Ltd Métodos e composições para geração de óxido nítrico e usos dos mesmos
JP7686578B2 (ja) 2019-06-04 2025-06-02 サーティー レスピラトリー リミテッド 窒素酸化物を生成するための方法および組成物、ならびに気道を介して窒素酸化物を送達するためのそれらの使用
BR112021025291A2 (pt) * 2019-06-12 2022-05-10 Sanotize Res And Development Corp Dispositivos de contenção de medicamento e composições associadas
EP4126087A1 (en) 2020-04-02 2023-02-08 T.J.Smith and Nephew,Limited Wound dressing control and activation
GB202004868D0 (en) * 2020-04-02 2020-05-20 Smith & Nephew Wound care compositions and methods of preparation thereof
AU2021259360A1 (en) 2020-04-23 2022-12-01 Thirty Respiratory Limited Nitric oxide or nitric oxide releasing compositions for use in treating SARS-CoV and SARS-CoV-2
CN115768413B (zh) 2020-04-23 2025-10-24 三十呼吸有限公司 用于治疗及抗击结核病的方法和组合物
CN113101053A (zh) * 2021-03-30 2021-07-13 上海健康医学院 一种可释放一氧化氮的创伤敷料
WO2022268369A1 (de) 2021-06-23 2022-12-29 Beiersdorf Ag Hautabdeckung, zur erhöhung der no konzentration in der haut
GB202114294D0 (en) * 2021-10-06 2021-11-17 Smith & Nephew Wound dressing apparatuses and methods for nitric oxide delivery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002521526A (ja) * 1998-07-31 2002-07-16 ファースト ウォーター リミテッド 疎水性ポリマーを含む生体接着剤組成物
GB9905425D0 (en) 1999-03-09 1999-05-05 Queen Mary & Westfield College Pharmaceutical composition
GB0021317D0 (en) * 2000-08-30 2000-10-18 Queen Mary & Westfield College Transdermal pharmaceutical delivery composition
CA2323382C (en) * 2000-10-17 2004-04-13 Pharma Mag Inc. Wound dressing
GB0715556D0 (en) * 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
GB0715554D0 (en) * 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
US20100055161A1 (en) * 2008-08-27 2010-03-04 Dong June Ahn Hydrogel face mask for delivering skin care agents
WO2011076216A2 (en) * 2009-12-22 2011-06-30 Rigshospitalet, Copenhagen University Hospital Wound care products

Also Published As

Publication number Publication date
US20160082142A1 (en) 2016-03-24
PT2908872T (pt) 2018-03-08
RS56954B1 (sr) 2018-05-31
LT2908872T (lt) 2018-03-12
NO2908872T3 (cg-RX-API-DMAC7.html) 2018-04-14
HUE038361T2 (hu) 2018-10-29
JP6559655B2 (ja) 2019-08-14
EP2908872A1 (en) 2015-08-26
ES2661643T3 (es) 2018-04-02
JP2016522829A (ja) 2016-08-04
AU2014270115A1 (en) 2015-12-03
CN105579074B (zh) 2018-04-10
CN105579074A (zh) 2016-05-11
WO2014188174A1 (en) 2014-11-27
PL2908872T3 (pl) 2018-06-29
GB201309091D0 (en) 2013-07-03
DK2908872T3 (en) 2018-02-26
US9662414B2 (en) 2017-05-30
AU2014270115B2 (en) 2017-12-21
SA515370167B1 (ar) 2017-10-05
EP2908872B1 (en) 2017-11-15

Similar Documents

Publication Publication Date Title
HRP20180275T1 (hr) Sustav zavoja
HRP20180079T1 (hr) Transdermalni sustav za isporuku
JP2016522829A5 (cg-RX-API-DMAC7.html)
JP2016518458A5 (cg-RX-API-DMAC7.html)
CL2012003470A1 (es) Una composicion solida que comprende 1) un compuesto inhibidor del hcv de formula definida, o una sal farmaceuticamente aceptable de este, en una forma amorfa, 2) un polimero hidrofilico, y opcionalmente 3) un agente tensoactivo; su proceso de preparacion, util para tratar una infeccion del hcv.
PH12020551597A1 (en) Treatment of hidradenitis suppurativa using jak inhibitors
BR112013031464A2 (pt) métodos e membros de contato com a ferida
BR112014031439A2 (pt) dispositivos e curativos hemostáticos e para feridas e processos para produzir dispositivo hemostático e para tratar feridas
EP2575884A4 (en) APPLICATIONS AND COMPOSITIONS FOR THE TREATMENT OF ACNE INVERSA
ATE462438T1 (de) Verwendung von carrageenan zur behandlung von rhinovirus-infektionen
EA201300704A1 (ru) Трансдермальная терапевтическая система для введения активного вещества
NZ710890A (en) Neosaxitoxin combination formulations for prolonged local anesthesia
BR112015025805A2 (pt) compostos de ligação de nh3 e métodos para inibir o transporte de fosfato
ITMI20051415A1 (it) Biomateriali a base di corbossimetilcellulosa salificata con zinco associata a derivati dell'acido ialuronico da impiegarsi come dispositivi medici con attivita' antimicrobica ed antifungina e loro processo di produzione
PH12013500857A1 (en) Methods and compositions for treating hiv-associated diarrhea
MX2025002705A (es) Isoquinolonas como inhibidores de pi3k
PT1973540E (pt) Utilização de derivados heterocíclicos benzo-fundidos de sulfamida para o tratamento de dor
NZ631279A (en) Method for treatment of labor arrest
FR2978665B1 (fr) Composition antiseptique
MY169911A (en) Thermally conductive, metal-based bandages to aid in medical healing and methods of use
Augustine et al. Pseudomonas aeruginosa wound infections: a critical appraisal of topical antiseptics
CL2008001282A1 (es) Composicion farmaceutica con actividad antimicrobiana que comprende un aminoacidos n halogenado y un agente antiinflamatorio; uso para prevenir o tratar una infeccion de tejidos, donde dicho tejido es ocular, nasal, seno nasal o dermico o una infeccion respiratoria.
NZ604009A (en) A combination composition comprising ibuprofen and paracetamol
CN108210989A (zh) 一种液体创可贴
CN103156730A (zh) 异种脱细胞真皮基质护创系统